AGP Picks
View all

Sci-Tech Today Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today Bhutan.

Press releases published on September 22, 2026

ROG G1000 Gaming Desktop Brings Top-Tier Performance and Is Now Available to Order
Fullstory Survey: 77% of Consumers Have Switched Gaming Platforms Because of User Experience
Chief Media Launches CMX Direct, Bringing Cross-Media Buying and Measurement Directly to Brands and Agencies
Babcock and Arqit demonstrate secure communications network designed to counter future quantum-enabled threats
Aurigo Software Achieves ISO/IEC 42001 Certification for Artificial Intelligence Management
AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib
Forge Nano and Nanexa Enter Joint Development Agreement to Advance Manufacturing for ALD-Coated PharmaShell® Long-Acting Injectable Medicines
MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer
Yuethai Hydraulics Marks 20 Years of Innovation and Reliability
365 Data Centers and Megaport Expand Partnership into Nine Additional Markets
Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD
Rocket Software Named as a Major Player in IDC MarketScape® for Intelligent Content Services
Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker
Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015
Other World Computing (OWC) Wins Tech & Learning Awards of Excellence: Back to School 2026!
Marchex Expands Investor Relations Program, Engages PondelWilkinson to Broaden Investor Outreach
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
Caseware Named as Finalist in Three Categories at the 2026 A.I. Awards
Elevar Therapeutics Receives FDA Conditional Acceptance of LYRFIGTU as Brand Name for Lirafugratinib

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech Today Bhutan

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.